IBDEI0X3 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16086,0)
 ;;=780.97^^81^951^21
 ;;^UTILITY(U,$J,358.3,16086,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16086,1,4,0)
 ;;=4^780.97
 ;;^UTILITY(U,$J,358.3,16086,1,5,0)
 ;;=5^Altered Mental Status
 ;;^UTILITY(U,$J,358.3,16086,2)
 ;;=^334164
 ;;^UTILITY(U,$J,358.3,16087,0)
 ;;=793.99^^81^951^15
 ;;^UTILITY(U,$J,358.3,16087,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16087,1,4,0)
 ;;=4^793.99
 ;;^UTILITY(U,$J,358.3,16087,1,5,0)
 ;;=5^Abnormal X-Ray Finding
 ;;^UTILITY(U,$J,358.3,16087,2)
 ;;=^334168
 ;;^UTILITY(U,$J,358.3,16088,0)
 ;;=787.20^^81^951^55
 ;;^UTILITY(U,$J,358.3,16088,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16088,1,4,0)
 ;;=4^787.20
 ;;^UTILITY(U,$J,358.3,16088,1,5,0)
 ;;=5^Dysphagia
 ;;^UTILITY(U,$J,358.3,16088,2)
 ;;=^335307
 ;;^UTILITY(U,$J,358.3,16089,0)
 ;;=789.59^^81^951^26
 ;;^UTILITY(U,$J,358.3,16089,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16089,1,4,0)
 ;;=4^789.59
 ;;^UTILITY(U,$J,358.3,16089,1,5,0)
 ;;=5^Ascites
 ;;^UTILITY(U,$J,358.3,16089,2)
 ;;=^335282
 ;;^UTILITY(U,$J,358.3,16090,0)
 ;;=790.6^^81^951^13
 ;;^UTILITY(U,$J,358.3,16090,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16090,1,4,0)
 ;;=4^790.6
 ;;^UTILITY(U,$J,358.3,16090,1,5,0)
 ;;=5^Abnormal LFT's
 ;;^UTILITY(U,$J,358.3,16090,2)
 ;;=^87228
 ;;^UTILITY(U,$J,358.3,16091,0)
 ;;=790.29^^81^951^86
 ;;^UTILITY(U,$J,358.3,16091,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16091,1,4,0)
 ;;=4^790.29
 ;;^UTILITY(U,$J,358.3,16091,1,5,0)
 ;;=5^Hyperglycemia (NOT DM)
 ;;^UTILITY(U,$J,358.3,16091,2)
 ;;=^329955
 ;;^UTILITY(U,$J,358.3,16092,0)
 ;;=780.60^^81^951^71
 ;;^UTILITY(U,$J,358.3,16092,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16092,1,4,0)
 ;;=4^780.60
 ;;^UTILITY(U,$J,358.3,16092,1,5,0)
 ;;=5^Fever
 ;;^UTILITY(U,$J,358.3,16092,2)
 ;;=^336764
 ;;^UTILITY(U,$J,358.3,16093,0)
 ;;=784.59^^81^951^139
 ;;^UTILITY(U,$J,358.3,16093,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16093,1,4,0)
 ;;=4^784.59
 ;;^UTILITY(U,$J,358.3,16093,1,5,0)
 ;;=5^Speech Disturbance NEC
 ;;^UTILITY(U,$J,358.3,16093,2)
 ;;=^338287
 ;;^UTILITY(U,$J,358.3,16094,0)
 ;;=799.21^^81^951^115
 ;;^UTILITY(U,$J,358.3,16094,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16094,1,4,0)
 ;;=4^799.21
 ;;^UTILITY(U,$J,358.3,16094,1,5,0)
 ;;=5^Nervousness
 ;;^UTILITY(U,$J,358.3,16094,2)
 ;;=^338291
 ;;^UTILITY(U,$J,358.3,16095,0)
 ;;=786.30^^81^951^82
 ;;^UTILITY(U,$J,358.3,16095,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16095,1,4,0)
 ;;=4^786.30
 ;;^UTILITY(U,$J,358.3,16095,1,5,0)
 ;;=5^Hemoptysis
 ;;^UTILITY(U,$J,358.3,16095,2)
 ;;=^339669
 ;;^UTILITY(U,$J,358.3,16096,0)
 ;;=787.60^^81^951^92
 ;;^UTILITY(U,$J,358.3,16096,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16096,1,4,0)
 ;;=4^787.60
 ;;^UTILITY(U,$J,358.3,16096,1,5,0)
 ;;=5^Incontinence of Feces
 ;;^UTILITY(U,$J,358.3,16096,2)
 ;;=^339670
 ;;^UTILITY(U,$J,358.3,16097,0)
 ;;=780.61^^81^951^72
 ;;^UTILITY(U,$J,358.3,16097,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16097,1,4,0)
 ;;=4^780.61
 ;;^UTILITY(U,$J,358.3,16097,1,5,0)
 ;;=5^Fever in Other Conditions
 ;;^UTILITY(U,$J,358.3,16097,2)
 ;;=^336667
 ;;^UTILITY(U,$J,358.3,16098,0)
 ;;=780.62^^81^951^73
 ;;^UTILITY(U,$J,358.3,16098,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16098,1,4,0)
 ;;=4^780.62
 ;;^UTILITY(U,$J,358.3,16098,1,5,0)
 ;;=5^Fever,Postprocedural
 ;;^UTILITY(U,$J,358.3,16098,2)
 ;;=^336668
 ;;^UTILITY(U,$J,358.3,16099,0)
 ;;=780.63^^81^951^74
 ;;^UTILITY(U,$J,358.3,16099,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16099,1,4,0)
 ;;=4^780.63
 ;;^UTILITY(U,$J,358.3,16099,1,5,0)
 ;;=5^Fever,Postvaccination
 ;;^UTILITY(U,$J,358.3,16099,2)
 ;;=^336669
 ;;
 ;;$END ROU IBDEI0X3
